Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue ▾	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ALEC	Alector, Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.05M	-$142.93M	-679.2%	-466.3%	-79.1%	-$1.39
LENZ	LENZ Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$19.09M	-$82.13M	-430.3%	-28.9%	n/a	-$2.85
PTHS	Pelthos Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$16.80M	-$43.32M	-257.9%	-111.4%	n/a	-$23.04
RLAY	Relay Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$15.36M	-$276.48M	n/m	-48.8%	53.4%	-$1.61
LCTX	Lineage Cell Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.56M	-$63.53M	-436.5%	-146.6%	53.2%	-$0.28
CRBU	Caribou Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.16M	-$148.12M	n/m	-121.2%	11.7%	-$1.59
TCRX	TScan Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.32M	-$129.77M	n/m	-105.4%	266.7%	-$1.00
ACOG	Alpha Cognition Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.22M	-$20.67M	-202.2%	-33.1%	n/a	-$1.18
TSHA	Taysha Gene Therapies, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.77M	-$109.00M	n/m	-44.1%	17.3%	-$0.34
CRIS	Curis Inc Manufacturing · Year ended 2025-12-31 · USD	$9.44M	-$7.58M	-80.3%	-138.8%	-13.4%	-$0.58
FATE	Fate Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$6.65M	-$136.31M	n/m	-65.8%	-51.2%	-$1.15
DBVT	DBV Technologies S.A. Manufacturing · Year ended 2025-12-31 · USD	$5.64M	-$146.95M	n/m	-87.1%	35.8%	-$1.05
ZEOX	Zeo ScientifiX, Inc. Manufacturing · Year ended 2025-10-31 · USD	$5.20M	-$5.52M	-106.2%	n/a	12.5%	-$0.86
PRME	Prime Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.63M	-$201.14M	n/m	-166.4%	55.3%	-$1.35
OCGN	Ocugen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.41M	-$67.85M	n/m	n/a	8.8%	n/a
CGON	CG Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.04M	-$161.00M	n/m	-21.4%	254.7%	-$2.08
CRSP	CRISPR Therapeutics AG Manufacturing · Year ended 2025-12-31 · USD	$3.51M	-$581.60M	n/m	-30.3%	-90.6%	-$6.47
SRZN	Surrozen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.48M	-$242.03M	n/m	n/a	-67.4%	-$32.37
DYAI	Dyadic International Inc Manufacturing · Year ended 2025-12-31 · USD	$3.09M	-$7.36M	-238.3%	-597.6%	-11.6%	-$0.23
ALGS	Aligos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.19M	-$24.19M	n/m	-45.2%	-39.5%	-$2.45
HUMA	Humacyte, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$40.83M	n/m	n/m	n/a	-$0.26
OTLK	Outlook Therapeutics, Inc. Manufacturing · Year ended 2025-09-30 · USD	$1.41M	-$62.42M	n/m	n/a	n/a	-$1.79
SCNI	Scinai Immunotherapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	$1.31M	-$8.31M	-633.6%	-102.5%	99.2%	n/a
INBX	Inhibrx Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.30M	-$140.06M	n/m	n/m	550.0%	-$9.04
PLUR	Pluri Inc. Manufacturing · Year ended 2026-06-30 · USD	$1.02M	-$23.82M	n/m	n/a	-24.0%	-$2.44

Rows per page: 2550 100